Vivian Bykerk, BSc, MD, from Hospital for Special Surgery, answers our questions on new research about the impact of HLA-DRB1 risk alleles on the clinical efficacy of 2 biologic agents for the...
Dr Karpouzas talks about his study that evaluated the influence of distinct domains of rheumatoid arthritis disease activity, functional limitation, mood disturbance, as well as RA-specific knowledge...
Vanessa Kronzer, MD, from the Mayo Clinic, answers our questions about her study that assessed the association between rheumatoid arthritis, asthma, passive smoke exposure, and more.
William G. Dixon, MRCP, MSc, PhD, answers our questions about remote monitoring of RA and how it may improve the collection of patient-generated health data to benefit the overall management of RA.
In this podcast, Iris Navarro-Millán, MD, MSPH, from Hospital for Special Surgery, discusses shared decision-making in rheumatoid arthritis, the importance of a rheumatologist understanding patient...
A new analysis of the ArthritisPower registry aimed to identify factors that patients believe influenced their physician’s treatment decisions. Lead authors W. Benjamin Nowell, PhD, and Kelly Gavigan, MPH,...
Jeffrey Ruth, PhD, from the University of Michigan Medical School, answers our questions about his research on the role of inhibitor of DNA binding 1 protein in rheumatoid arthritis.
Jeffrey Ruth, PhD, from the University of Michigan Medical School, answers our questions about his research on the role of inhibitor of DNA binding 1 protein in rheumatoid arthritis.
